MPH Health Care 

Operating as an investment firm, MPH Health Care AG primarily focuses on the German healthcare sector. Its business activities include the manufacturing and distribution of medicinal products designed to treat conditions such as cancer, HIV, and various other chronic diseases. The company also provides medical aesthetic services and is involved in the development, marketing, and support of pharmaceutical and medical goods, including specialized medical devices for aesthetic surgery and cosmetic dermatology. Furthermore, MPH Health Care AG supplies cytostatic solutions and participates in real estate ventures. Established in Berlin, Germany, in 2008, the company adopted its current name in 2017, having previously been known as MPH Mittelständische Pharma Holding AG. It functions as a subsidiary of Magnum AG.